Coronary CTA for Coronary Artery Disease

BO
Overseen ByBonnie Ostergren
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

AI-Guided Coronary CT Angiography Screening in Former High-Intensity Athletes

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 30 years old or older.
Former professional or collegiate high-intensity athletes (e.g., NFL alumni, Division I athletes, or equivalent competitive-level participants)

Exclusion Criteria

Taking part in another research study that has not given their permission to participate in this one
I have a heart rhythm problem that is not controlled.
Pregnancy
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Assessment

Participants undergo a Coronary CTA and labs, with AI-guided analysis of CCTA images for plaque quantification and ischemia analysis

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the assessment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Coronary CTA

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: AthletesExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor Research Institute

Lead Sponsor

Trials
210
Recruited
205,000+

Cleerly, Inc.

Industry Sponsor

Trials
4
Recruited
45,200+